Osman Baspinar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Osman Baspinar has a total of 241 co-authors. Here are the top co-authors by number of shared publications:
Metin Kilinc
Department of Pediatric Cardiology Gaziantep University, Medical Faculty, Gaziantep Turkey
13 shared publicationsSevim Karaaslan
Department of Pediatrics, Selcuk University Meram Faculty of Medicine, Konya, Turkey
10 shared publications- Mehmet Kervancioglu
Department of Pediatric Cardiology, Gaziantep University Medical Faculty, Gaziantep, Turkey
9 shared publications Ahmet Irdem
Department of Pediatric Cardiology Gaziantep University, Medical Faculty, Gaziantep Turkey
7 shared publications- Ahmet Irdem
Faculty of Medicine, Department of Pediatric Cardiology, Çanakkale Onsekiz Mart University, Çanakkale, Türkiye
7 shared publications Ayse Balat
Department of Pediatric Nephrology, Faculty of Medicine, University of Gaziantep, Turkey
7 shared publications
Latest Publications
- 15 December 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (12) , 2511-2515
Paediatric cardiac tamponade requiring pericardiocentesis: aetiology and age distribution of 252 patients in a tertiary single-centre cohort
Objective: Cardiac tamponade is a rare but life-threatening condition in children, typically requiring urgent percutaneous pericardiocentesis. Despite its clinical importance, comprehensive data on paediatric cardiac tamponade are limited. Methods: We retrospectively reviewed 251 paediatric patients (0–18 years) with cardiac tamponade who underwent emergency percutaneous pericardiocentesis to evaluate the aetiological spectrum, age distribution, and associated clinical factors between November 2003 and May 2025. Diagnosis was based on echocardiographic criteria indicating haemodynamic compromise. Patients were categorised by age group, underlying aetiology, and recent history of cardiac intervention. Results: Structural heart diseases were the leading cause of cardiac tamponade (51.6%), particularly in neonates and infants. Pericardiocentesis was most frequently performed in children aged 6–12 years (28.2%). Cardiomyopathies were more prevalent in older age groups. Infectious causes were the second most common aetiology (11.5%). Cardiac Tamponade occurred more frequently following cardiac surgery (12.3%) than after catheter-based interventions. Iatrogenic tamponade was identified in six patients, most commonly during high-risk transcatheter procedures. Genetic syndromes were present in 30 patients, with Down syndrome being the most common. Conclusions: To the best of our knowledge, this study represents the largest single-centre cohort of paediatric cardiac tamponade requiring pericardiocentesis. Cardiac causes, particularly structural heart diseases, represent the most common aetiology across all age groups; therefore, these patients should be promptly evaluated for cardiac tamponade when presenting with relevant symptoms.
- 15 December 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (12) , 2511-2515
Paediatric cardiac tamponade requiring pericardiocentesis: aetiology and age distribution of 252 patients in a tertiary single-centre cohort
Objective: Cardiac tamponade is a rare but life-threatening condition in children, typically requiring urgent percutaneous pericardiocentesis. Despite its clinical importance, comprehensive data on paediatric cardiac tamponade are limited. Methods: We retrospectively reviewed 251 paediatric patients (0–18 years) with cardiac tamponade who underwent emergency percutaneous pericardiocentesis to evaluate the aetiological spectrum, age distribution, and associated clinical factors between November 2003 and May 2025. Diagnosis was based on echocardiographic criteria indicating haemodynamic compromise. Patients were categorised by age group, underlying aetiology, and recent history of cardiac intervention. Results: Structural heart diseases were the leading cause of cardiac tamponade (51.6%), particularly in neonates and infants. Pericardiocentesis was most frequently performed in children aged 6–12 years (28.2%). Cardiomyopathies were more prevalent in older age groups. Infectious causes were the second most common aetiology (11.5%). Cardiac Tamponade occurred more frequently following cardiac surgery (12.3%) than after catheter-based interventions. Iatrogenic tamponade was identified in six patients, most commonly during high-risk transcatheter procedures. Genetic syndromes were present in 30 patients, with Down syndrome being the most common. Conclusions: To the best of our knowledge, this study represents the largest single-centre cohort of paediatric cardiac tamponade requiring pericardiocentesis. Cardiac causes, particularly structural heart diseases, represent the most common aetiology across all age groups; therefore, these patients should be promptly evaluated for cardiac tamponade when presenting with relevant symptoms.
- Open Access
- 28 October 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (5) , 1036-1040
Very Rare Cause of Cardiomyopathy in a Child: Peripartum Cardiomyopathy
Background: Peripartum cardiomyopathy (PCMP) is characterized by severe systolic dysfunction of the heart, manifesting with signs and symptoms of heart failure in the last month of pregnancy or within the first five months postpartum in women with no previously known heart disease. Methods: A childhood-age pregnancy mother who presented to our emergency department at 3 months postpartum with complaints of dyspnea, orthopnea, edema, and palpitations. Following the diagnosis of PCMP, standard cardiomyopathy treatment was initiated alongside bromocriptine therapy. However, during follow-up, the patient died due to heart failure. PCMP, which is rare even in adult patients, can also occur in the pediatric age group. The using bromocriptine, which pediatric cardiologists may be less familiar with, in addition to standard heart failure therapy is needed to cure it, but the nature of the disease could be very severe.
- 28 October 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (5) , 1036-1040
Open AccessVery Rare Cause of Cardiomyopathy in a Child: Peripartum Cardiomyopathy
Background: Peripartum cardiomyopathy (PCMP) is characterized by severe systolic dysfunction of the heart, manifesting with signs and symptoms of heart failure in the last month of pregnancy or within the first five months postpartum in women with no previously known heart disease. Methods: A childhood-age pregnancy mother who presented to our emergency department at 3 months postpartum with complaints of dyspnea, orthopnea, edema, and palpitations. Following the diagnosis of PCMP, standard cardiomyopathy treatment was initiated alongside bromocriptine therapy. However, during follow-up, the patient died due to heart failure. PCMP, which is rare even in adult patients, can also occur in the pediatric age group. The using bromocriptine, which pediatric cardiologists may be less familiar with, in addition to standard heart failure therapy is needed to cure it, but the nature of the disease could be very severe.
- Open Access
- 17 July 2025
- Published by Galenos Yayinevi in Forbes Journal of Medicine
Ventricular Fibrillation Caused by a Low-Rate Pacemaker
Ventricular Fibrillation Caused by a Low-Rate Pacemaker - Forbes Journal of Medicine
- 17 July 2025
- Published by Galenos Yayinevi in Forbes Journal of Medicine
Open AccessVentricular Fibrillation Caused by a Low-Rate Pacemaker
Ventricular Fibrillation Caused by a Low-Rate Pacemaker - Forbes Journal of Medicine
- Open Access
- 13 June 2025
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 31 (3) , 146-151
Evaluation of Pulmonary Regurgitation in Pediatric Patients with Operated Tetralogy of Fallot Using Automated Right Ventricle Software
Objective: In this study, we aimed to evaluate right ventricular (RV) functions using four-dimensional echocardiography and an automated RV software in patients with residual pulmonary regurgitation following surgical repair of Tetralogy of Fallot. Methods: We evaluated 18 patients with pulmonary regurgitation after Tetralogy of Fallot repair. The Tomtec V2.0 software program was used for automated right ventricle assessment. The results were compared with those of an 11-person control group. The measurements of both groups were analyzed. Results: The mean age of the patient group was 11.3 ± 3.4 years, while that of the control group was 11.3 ± 2.9 years (p > 0.05). RV end-diastolic volume (EDV) was found to be higher in the patient group compared to the controls (116.6 ± 47.3 vs. 54.3 ± 23.4 ml, p < 0.001). The rate of age-related increase in RV EDV was also higher in the patient group. A strong positive correlation was found between RV EDV and age (p < 0.001). Conclusion: The use of Tomtec V2.0 automatic contour detection is a practical method for assessing RV function in patients who have undergone surgical correction of Tetralogy of Fallot. It can also be employed to determine whether patients meet the criteria for pulmonary valve replacement. The degree and consequences of RV dilation depend on the patient’s age and may be influenced by other factors.
- 13 June 2025
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 31 (3) , 146-151
Open AccessEvaluation of Pulmonary Regurgitation in Pediatric Patients with Operated Tetralogy of Fallot Using Automated Right Ventricle Software
Objective: In this study, we aimed to evaluate right ventricular (RV) functions using four-dimensional echocardiography and an automated RV software in patients with residual pulmonary regurgitation following surgical repair of Tetralogy of Fallot. Methods: We evaluated 18 patients with pulmonary regurgitation after Tetralogy of Fallot repair. The Tomtec V2.0 software program was used for automated right ventricle assessment. The results were compared with those of an 11-person control group. The measurements of both groups were analyzed. Results: The mean age of the patient group was 11.3 ± 3.4 years, while that of the control group was 11.3 ± 2.9 years (p > 0.05). RV end-diastolic volume (EDV) was found to be higher in the patient group compared to the controls (116.6 ± 47.3 vs. 54.3 ± 23.4 ml, p < 0.001). The rate of age-related increase in RV EDV was also higher in the patient group. A strong positive correlation was found between RV EDV and age (p < 0.001). Conclusion: The use of Tomtec V2.0 automatic contour detection is a practical method for assessing RV function in patients who have undergone surgical correction of Tetralogy of Fallot. It can also be employed to determine whether patients meet the criteria for pulmonary valve replacement. The degree and consequences of RV dilation depend on the patient’s age and may be influenced by other factors.
- 9 January 2024
- Published by Springer Nature in Pediatric Cardiology
- Vol. 45 (2) , 272-281
Percutaneous Closure of Hemodynamically Significant Postoperative Residual Ventricular Septal Defects
The experience with percutaneous closure of postoperative residual ventricular septal defects (VSDs) is expanding with improved device technology and techniques. To report our experience with percutaneous closure of residual VSDs after cardiac surgeries. Retrospective clinical data review of patients who had percutaneous closure of postoperative residual VSDs at our institution between 2010 and 2022. Patients’ demographics, procedural, and follow-up data were looked at. Twelve patients (50% males) with a median age of 9.2 years (range 0.9–22) were identified. Baseline surgeries were 8 tetralogy of Fallot corrections, 2 pulmonary bandings for large muscular VSD (mVSD) including 1 coarctation repair, 1 atrioventricular septal defect repair, 1 sub-aortic membrane resection-induced iatrogenic VSD, 1 isolated VSD closure, and 1 additional mVSD. Median duration between baseline surgery and percutaneous VSD closure was 2.2 years (range 0.2–8.3). Residual VSD shunting was secondary to surgical patch leakage in 8/12 patients. The median angiographic defect diameter was 6.8 mm (range 4.8–14). The defect was balloon-calibrated in 3/12 patients. Defects were tackled retrogradely in 3/9 patients. Amplatzer Membranous VSD occluder (n = 1), Lifetech Multifunctional (n = 5), Membranous (n = 1) and muscular VSD occluders (n = 2) and Occlutech Membranous (n = 1) and Muscular (n = 2) VSD occluders were used. The procedure was successful in 10/12 patients. Two devices embolized to the pulmonary artery and were snare-retrieved. Both patients were referred for surgery. The median follow-up was 1.3 years (range 0.1–12). Six-month ultrasound showed one trivial residual shunt and one mild right ventricular outflow obstruction. One patient is receiving targeted therapy for pulmonary hypertension at 2 years of follow-up. Transcatheter closure of postoperative residual VSDs is a feasible yet challenging intervention. Procedural complications can be encountered.
- 9 January 2024
- Published by Springer Nature in Pediatric Cardiology
- Vol. 45 (2) , 272-281
Percutaneous Closure of Hemodynamically Significant Postoperative Residual Ventricular Septal Defects
The experience with percutaneous closure of postoperative residual ventricular septal defects (VSDs) is expanding with improved device technology and techniques. To report our experience with percutaneous closure of residual VSDs after cardiac surgeries. Retrospective clinical data review of patients who had percutaneous closure of postoperative residual VSDs at our institution between 2010 and 2022. Patients’ demographics, procedural, and follow-up data were looked at. Twelve patients (50% males) with a median age of 9.2 years (range 0.9–22) were identified. Baseline surgeries were 8 tetralogy of Fallot corrections, 2 pulmonary bandings for large muscular VSD (mVSD) including 1 coarctation repair, 1 atrioventricular septal defect repair, 1 sub-aortic membrane resection-induced iatrogenic VSD, 1 isolated VSD closure, and 1 additional mVSD. Median duration between baseline surgery and percutaneous VSD closure was 2.2 years (range 0.2–8.3). Residual VSD shunting was secondary to surgical patch leakage in 8/12 patients. The median angiographic defect diameter was 6.8 mm (range 4.8–14). The defect was balloon-calibrated in 3/12 patients. Defects were tackled retrogradely in 3/9 patients. Amplatzer Membranous VSD occluder (n = 1), Lifetech Multifunctional (n = 5), Membranous (n = 1) and muscular VSD occluders (n = 2) and Occlutech Membranous (n = 1) and Muscular (n = 2) VSD occluders were used. The procedure was successful in 10/12 patients. Two devices embolized to the pulmonary artery and were snare-retrieved. Both patients were referred for surgery. The median follow-up was 1.3 years (range 0.1–12). Six-month ultrasound showed one trivial residual shunt and one mild right ventricular outflow obstruction. One patient is receiving targeted therapy for pulmonary hypertension at 2 years of follow-up. Transcatheter closure of postoperative residual VSDs is a feasible yet challenging intervention. Procedural complications can be encountered.
- Open Access
- 23 June 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 163
Piccolo in transcatheter PDA closure multicenter study from premature to adolescent children – CORRIGENDUM
- 23 June 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 163
Open AccessPiccolo in transcatheter PDA closure multicenter study from premature to adolescent children – CORRIGENDUM
- 7 June 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 157-162
Piccolo in transcatheter PDA closure multi-centre study from premature to adolescent children
In this multi-centre study, the mid- to long-term efficacy and safety of the Amplatzer Piccolo Occluder in patent ductus arteriosus closure in premature and term infants as well as children were discussed. Methods. Between 2016 and 2021, 645 patients, 152 of whom were less than 1 month old, underwent ductus closure with the Piccolo device from five different centres in Turkey. The median age of the patients was 2.2 years, and the mean narrowest point of duct diameter was 1.8 mm. Sixty-two patients weighed ≤ 1.5 kg, 90 patients 1.5–3 kg, and the mean follow-up was 20.4 months. In 396, the duct was closed by the retrograde route. Ductal anatomy was Type A in 285, C in 72, E in 171, and F in 64 patients. Fluoroscopy duration was 6.2 min. The procedure success rate was 99.1%. Device embolisation occurred in 13 patients (2%), and 11 were retrieved with a snare. Cardiac perforation and death developed in one premature baby. The left pulmonary artery and the descending aorta stenosis were observed in 3 (0.4%) and in 5 patients (0.5%). Results. Piccolo device is safe and effective in closing ductus in all age groups. It has low profile for use in premature and newborn babies, a small embolisation risk, and a low residual shunt rate after closure. Conclusion. The Piccolo device can be considered as close an ideal occluder. The lower profile, smaller delivery catheter size, and symmetry of this device allow for a venous or arterial approach.
- 7 June 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 157-162
Piccolo in transcatheter PDA closure multi-centre study from premature to adolescent children
In this multi-centre study, the mid- to long-term efficacy and safety of the Amplatzer Piccolo Occluder in patent ductus arteriosus closure in premature and term infants as well as children were discussed. Methods. Between 2016 and 2021, 645 patients, 152 of whom were less than 1 month old, underwent ductus closure with the Piccolo device from five different centres in Turkey. The median age of the patients was 2.2 years, and the mean narrowest point of duct diameter was 1.8 mm. Sixty-two patients weighed ≤ 1.5 kg, 90 patients 1.5–3 kg, and the mean follow-up was 20.4 months. In 396, the duct was closed by the retrograde route. Ductal anatomy was Type A in 285, C in 72, E in 171, and F in 64 patients. Fluoroscopy duration was 6.2 min. The procedure success rate was 99.1%. Device embolisation occurred in 13 patients (2%), and 11 were retrieved with a snare. Cardiac perforation and death developed in one premature baby. The left pulmonary artery and the descending aorta stenosis were observed in 3 (0.4%) and in 5 patients (0.5%). Results. Piccolo device is safe and effective in closing ductus in all age groups. It has low profile for use in premature and newborn babies, a small embolisation risk, and a low residual shunt rate after closure. Conclusion. The Piccolo device can be considered as close an ideal occluder. The lower profile, smaller delivery catheter size, and symmetry of this device allow for a venous or arterial approach.
- Open Access
- 19 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (4)
A Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Toward Transcatheter Closure
- 19 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (4)
Open AccessA Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Toward Transcatheter Closure
- 27 September 2022
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 28 (3) , 242-246
Investigation of DEL22 Frequency with Fluorescent In Situ Hybridization Method in Children with Conotruncal Heart Anomaly
Conotruncal heart defects,Del22,FISH,22q11.2
- 27 September 2022
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 28 (3) , 242-246
Investigation of DEL22 Frequency with Fluorescent In Situ Hybridization Method in Children with Conotruncal Heart Anomaly
Conotruncal heart defects,Del22,FISH,22q11.2